ID

12762

Beschreibung

Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT01213368

Link

https://clinicaltrials.gov/show/NCT01213368

Stichworte

  1. 21.12.15 21.12.15 -
Hochgeladen am

21. Dezember 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Atrial Fibrillation NCT01213368

Eligibility Atrial Fibrillation NCT01213368

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients of aged 20 years or more.
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
permanent atrial fibrillation [af] (defined as duration of af > 6 months) for which cardioversion is not considered and with resting ventricular heart rate ≥ 80 bpm at screening.
Beschreibung

atrial fibrillation permanent; ventricular heart rate resting

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0205355
UMLS CUI [2,1]
C1883530
UMLS CUI [2,2]
C0679218
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
unstable angina pectoris.
Beschreibung

unstable angina pectoris

Datentyp

boolean

Alias
UMLS CUI [1]
C0002965
history of torsades de pointes.
Beschreibung

torsades de pointes

Datentyp

boolean

Alias
UMLS CUI [1]
C0040479
prolonged qt corrected interval (≥ 500 ms).
Beschreibung

Prolonged QTc

Datentyp

boolean

Alias
UMLS CUI [1]
C0151878
third degree atrioventricular block (avb) on the screening ecg while in af or, documentation on previous ecgs while in sinus rhythm of pr-interval > 0.28 sec or high degree avb (2nd degree or higher) or, significant sinus node disease (documented pause ≥ 3 sec) - without a permanent pacemaker implanted.
Beschreibung

atrioventricular block; pacemaker implantation permanent

Datentyp

boolean

Alias
UMLS CUI [1]
C0004245
UMLS CUI [2,1]
C0189842
UMLS CUI [2,2]
C0205355
congestive heart failure (chf) of new york heart association classification (nyha) class iv or recent (within 1 month prior to randomization) unstable nyha class iii.
Beschreibung

congestive heart failure; new york heart association classification

Datentyp

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C1275491
treatment with other class i or iii anti-arrhythmic drugs.
Beschreibung

anti-arrhythmic drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0003195
patients treated with amiodarone during the 4 weeks preceding randomization.
Beschreibung

amiodarone

Datentyp

boolean

Alias
UMLS CUI [1]
C0002598
clinically relevant haematologic, hepatic, gastro-intestinal, renal, pulmonary, endocrinologic (in particular thyroid) or psychiatric disease.
Beschreibung

Comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
hypokalemia and hypomagnesemia must be corrected before randomization.
Beschreibung

hypokalemia; hypomagnesemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0020621
UMLS CUI [2]
C0151723
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430

Ähnliche Modelle

Eligibility Atrial Fibrillation NCT01213368

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
patients of aged 20 years or more.
boolean
C0001779 (UMLS CUI [1])
atrial fibrillation permanent; ventricular heart rate resting
Item
permanent atrial fibrillation [af] (defined as duration of af > 6 months) for which cardioversion is not considered and with resting ventricular heart rate ≥ 80 bpm at screening.
boolean
C0004238 (UMLS CUI [1,1])
C0205355 (UMLS CUI [1,2])
C1883530 (UMLS CUI [2,1])
C0679218 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
unstable angina pectoris
Item
unstable angina pectoris.
boolean
C0002965 (UMLS CUI [1])
torsades de pointes
Item
history of torsades de pointes.
boolean
C0040479 (UMLS CUI [1])
Prolonged QTc
Item
prolonged qt corrected interval (≥ 500 ms).
boolean
C0151878 (UMLS CUI [1])
atrioventricular block; pacemaker implantation permanent
Item
third degree atrioventricular block (avb) on the screening ecg while in af or, documentation on previous ecgs while in sinus rhythm of pr-interval > 0.28 sec or high degree avb (2nd degree or higher) or, significant sinus node disease (documented pause ≥ 3 sec) - without a permanent pacemaker implanted.
boolean
C0004245 (UMLS CUI [1])
C0189842 (UMLS CUI [2,1])
C0205355 (UMLS CUI [2,2])
congestive heart failure; new york heart association classification
Item
congestive heart failure (chf) of new york heart association classification (nyha) class iv or recent (within 1 month prior to randomization) unstable nyha class iii.
boolean
C0018802 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
anti-arrhythmic drugs
Item
treatment with other class i or iii anti-arrhythmic drugs.
boolean
C0003195 (UMLS CUI [1])
amiodarone
Item
patients treated with amiodarone during the 4 weeks preceding randomization.
boolean
C0002598 (UMLS CUI [1])
Comorbidity
Item
clinically relevant haematologic, hepatic, gastro-intestinal, renal, pulmonary, endocrinologic (in particular thyroid) or psychiatric disease.
boolean
C0009488 (UMLS CUI [1])
hypokalemia; hypomagnesemia
Item
hypokalemia and hypomagnesemia must be corrected before randomization.
boolean
C0020621 (UMLS CUI [1])
C0151723 (UMLS CUI [2])
informed consent
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C0021430 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video